Literature DB >> 34917318

Important relation between self-efficacy, sense of coherence, illness perceptions, depression and anxiety in patients with inflammatory bowel disease.

Adi Eindor-Abarbanel1, Timna Naftali2, Nahum Ruhimovich2, Ariella Bar-Gil Shitrit3, Fabiana Sklerovsky-Benjaminov2, Fred Konikoff2, Shay Matalon1, Haim Shirin1, Yael Milgrom3, Tomer Ziv-Baran4, Efrat Broide1.   

Abstract

INTRODUCTION: Anxiety and depression are common disturbances in patients with inflammatory bowel diseases (IBD), and were found to impact the disease course. Illness perceptions (IPs), self-efficacy (SE) and sense of coherence (SOC) are important psychological functions, used by the individual to cope with his chronic disease. AIMS: to investigate the association of IP, SE and SOC on anxiety and depression among patients with IBD. PATIENTS AND METHODS: Patients filled questionnaires including: demographic, socioeconomic and clinical features. Depression and anxiety were assessed using the Hospital Anxiety and Depression Scale. IP, SE and SOC were assessed using the Brief Illness perception Questionnaire, IBD-SE and SOC scales.
RESULTS: The study sample consisted of 299 patients with IBD, median age 34.15, 63% females, 70.9% had Crohn's disease, filled the questionnaires. In the multivariate analysis, lower results in IP, SE and SOC were found to be associated with significantly increase anxiety (OR 8.35, p<0.001; OR 4.18, p=0.001; OR 4.67, p<0.001, respectively) and depression (OR 15.8, p=0.001; OR 10.99, p=0.029; OR 6.12, p=0.014.
CONCLUSIONS: Anxiety and depression are associated with IP, SE and SOC in patients with IBD. Clinicians should be aware of this impact, recognise their patients' psychological abilities to cope with the disease and improve those abilities, when needed, in order to achieve a better coping with the disease and to prevent the development of anxiety and depression. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  inflammatory bowel disease; psychological stress; psychology; psychosomatic medicine; quality of life

Year:  2020        PMID: 34917318      PMCID: PMC8640387          DOI: 10.1136/flgastro-2020-101412

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  29 in total

1.  Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.

Authors:  Esme Fuller-Thomson; Joanne Sulman
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

2.  Differences Across Illness Perceptions in Inflammatory Bowel Disease and Their Relationships to Psychological Distress and Quality of Life.

Authors:  Davina Tribbick; Michael Salzberg; William Connell; Finlay Macrae; Michael Kamm; Glen Bates; Georgina Cunningham; David Austin; Simon Knowles
Journal:  Gastroenterol Nurs       Date:  2017 Jul/Aug       Impact factor: 0.978

3.  Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon.

Authors:  Branislav-R Filipović; Branka-F Filipović; Mirko Kerkez; Nikola Milinić; Tomislav Randelović
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

4.  Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Michael P Jones; Sarah Wessinger; Michael D Crowell
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

5.  Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Authors:  J Y Mary; R Modigliani
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

6.  Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit.

Authors:  Gastão L F Soares-Filho; Rafael C Freire; Karla Biancha; Ticiana Pacheco; André Volschan; Alexandre M Valença; Antonio E Nardi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Authors:  Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

Review 9.  Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management.

Authors:  Lesley A Graff; John R Walker; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

10.  Sense of coherence in patients with inflammatory bowel disease.

Authors:  Randi Opheim; May Solveig Fagermoen; Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Bjørn Moum
Journal:  Gastroenterol Res Pract       Date:  2014-01-02       Impact factor: 2.260

View more
  3 in total

1.  Prevalence of anxiety and depressive symptoms in ulcerative colitis patients in Jordan and its relationship to patient-reported disease activity.

Authors:  Awni Abu Sneineh; Sara Haj Ali; Ahmad Al-Masri; Amr Diab; Farah Aldweik; Mohammad Darweesh; Mohammad Qaisi; Osama Alshakhatreh; Tarek Tamimi; Yaser Rayyan; Radwan Banimustafa; Ibrahim Sablaban
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

2.  Self-Care and Sense of Coherence: A Salutogenic Model for Health and Care in Nursing Education.

Authors:  Natura Colomer-Pérez; Joan J Paredes-Carbonell; Carmen Sarabia-Cobo; Sergio A Useche; Vicente Gea-Caballero
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

3.  Symptoms of Anxiety and Depression and Sense of Coherence in Patients Undergoing Carotid Artery Stenting.

Authors:  Magdalena Piegza; Izabela Jaworska; Kamil Bujak; Paweł Dębski; Łukasz Kunert; Karina Badura-Brzoza; Maciej Żerdziński; Michał Błachut; Jacek Piegza
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.